 | • レポートコード：MRC2211A095 • 出版社/出版日：Transparency Market Research / 2022年8月 • レポート形態：英文、PDF、190ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界の関節痛注射市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、関節種類別（膝＆足首、股関節、肩＆肘、脊椎椎間関節、その他）分析、流通チャネル別（病院薬局、オンライン薬局、小売薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を掲載しています。なお、当書には、Allergan plc、Pfizer, Inc.、Sanofi、Anika Therapeutics, Inc.、Ferring B.V.、Bioventus、Flexion Therapeutics, Inc.、Zimmer Biomet Holdings, Inc.、Seikagaku Corporation、Chugai Pharmaceutical Co., Ltd.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の関節痛注射市場規模：関節種類別 - 膝＆足首関節痛注射の市場規模 - 股関節痛注射の市場規模 - 肩＆肘関節痛注射の市場規模 - 脊椎椎間関節痛注射の市場規模 - その他関節痛注射の市場規模 ・世界の関節痛注射市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - オンライン薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 ・世界の関節痛注射市場規模：地域別 - 北米の関節痛注射市場規模 - ヨーロッパの関節痛注射市場規模 - アジア太平洋の関節痛注射市場規模 - 中南米の関節痛注射市場規模 - 中東・アフリカの関節痛注射市場規模 ・競争状況 |
Joint Pain Injections Market – Scope of Report
TMR’s report on the global joint pain injections market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global joint pain injections market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global joint pain injections market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the joint pain injections market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global joint pain injections market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global joint pain injections market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global joint pain injections market.
The report delves into the competitive landscape of the global joint pain injections market. Key players operating in the global joint pain injections market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global joint pain injections market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market joint pain injections.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Joint Pain Injections Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Joint Pain Injections Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis
5.4. Disease Prevalence & Incidence Rate globally with key countries
5.5. Covid-19 Impact Analysis
6. Global Joint Pain Injections Market Analysis and Forecast, by Joint Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Joint Type, 2017–2031
6.3.1. Knee & Ankle
6.3.2. Hip Joint
6.3.3. Shoulder & Elbow
6.3.4. Facet Joints of Spine
6.3.5. Others
6.4. Market Attractiveness Analysis, by Joint Type
7. Global Joint Pain Injections Market Analysis and Forecast, by Injection Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Injection Type, 2017–2031
7.3.1. Corticosteroid Injections
7.3.2. Hyaluronic Acid Injections
7.3.3. Others
7.4. Market Attractiveness Analysis, by Injection Type
8. Global Joint Pain Injections Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Online Pharmacies
8.3.3. Retail Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Joint Pain Injections Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Joint Pain Injections Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Joint Type, 2017–2031
10.2.1. Knee & Ankle
10.2.2. Hip Joint
10.2.3. Shoulder & Elbow
10.2.4. Facet Joints of Spine
10.2.5. Others
10.3. Market Value Forecast, by Injection Type, 2017–2031
10.3.1. Corticosteroid Injections
10.3.2. Hyaluronic Acid Injections
10.3.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Hospital Pharmacies
10.4.2. Online Pharmacies
10.4.3. Retail Pharmacies
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Joint Type
10.6.2. By Injection Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Joint Pain Injections Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Joint Type, 2017–2031
11.2.1. Knee & Ankle
11.2.2. Hip Joint
11.2.3. Shoulder & Elbow
11.2.4. Facet Joints of Spine
11.2.5. Others
11.3. Market Value Forecast, by Injection Type, 2017–2031
11.3.1. Corticosteroid Injections
11.3.2. Hyaluronic Acid Injections
11.3.3. Others
11.4. Market Value Forecast, by Distribution Channel, 2017–2031
11.4.1. Hospital Pharmacies
11.4.2. Online Pharmacies
11.4.3. Retail Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Joint Type
11.6.2. By Injection Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Joint Pain Injections Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Joint Type, 2017–2031
12.2.1. Knee & Ankle
12.2.2. Hip Joint
12.2.3. Shoulder & Elbow
12.2.4. Facet Joints of Spine
12.2.5. Others
12.3. Market Value Forecast, by Injection Type, 2017–2031
12.3.1. Corticosteroid Injections
12.3.2. Hyaluronic Acid Injections
12.3.3. Others
12.4. Market Value Forecast, by Distribution Channel, 2017–2031
12.4.1. Hospital Pharmacies
12.4.2. Online Pharmacies
12.4.3. Retail Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Joint Type
12.6.2. By Injection Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Joint Pain Injections Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Joint Type, 2017–2031
13.2.1. Knee & Ankle
13.2.2. Hip Joint
13.2.3. Shoulder & Elbow
13.2.4. Facet Joints of Spine
13.2.5. Others
13.3. Market Value Forecast, by Injection Type, 2017–2031
13.3.1. Corticosteroid Injections
13.3.2. Hyaluronic Acid Injections
13.3.3. Others
13.4. Market Value Forecast, by Distribution Channel, 2017–2031
13.4.1. Hospital Pharmacies
13.4.2. Online Pharmacies
13.4.3. Retail Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Joint Type
13.6.2. By Injection Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Joint Pain Injections Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Joint Type, 2017–2031
14.2.1. Knee & Ankle
14.2.2. Hip Joint
14.2.3. Shoulder & Elbow
14.2.4. Facet Joints of Spine
14.2.5. Others
14.3. Market Value Forecast, by Injection Type, 2017–2031
14.3.1. Corticosteroid Injections
14.3.2. Hyaluronic Acid Injections
14.3.3. Others
14.4. Market Value Forecast, by Distribution Channel, 2017–2031
14.4.1. Hospital Pharmacies
14.4.2. Online Pharmacies
14.4.3. Retail Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Joint Type
14.6.2. By Injection Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Pfizer, Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Anika Therapeutics, Inc.
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Bioventus
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Eli Lilly and Company
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Ferring B.V.
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Pacira BioSciences, Inc. (Flexion Therapeutics)
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Sanofi
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Seikagaku Corporation
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Zimmer Biomet
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
Table 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 02: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 03: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 04: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Region , 2017–2031
Table 05: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 07: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 08: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 09: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 11: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 12: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 14: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 15: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 16: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 18: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 19: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 20: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031
Table 22: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031
Table 23: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031